Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lanska

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 28, 2017
Apheresis data registration in WWA registry-10-year experience of our centerM Blaha, M Lanska, H Tomsova, et al.
Neurology|April 1, 2016
Author ResponseDouglas J Lanska, James M Lanska, Bernd F Remler
Neurology|June 3, 2015
Description and clinical application of the Pulfrich effectDouglas J Lanska, James M Lanska, Bernd F Remler
Atherosclerosis. Supplements|May 5, 2015
Pregnancy in homozygous familial hypercholesterolemia--Importance of LDL-apheresisM Blaha, M Lanska, V Blaha, et al.
Biomed Research International|October 3, 2014
Timing of peripheral blood stem cell yield: comparison of alternative methods with the classic method for CD34+ cell determinationI Fatorova, M Blaha, M Lanska, et al.
Journal of Biomedicine & Biotechnology|March 20, 2010
Extracorporeal immunoglobulin elimination for the treatment of severe myasthenia gravisM Blaha, J Pit'ha, V Blaha, et al.
Atherosclerosis. Supplements|January 30, 2013
Rheohaemapheresis in the treatment of nonvascular age-related macular degenerationM Blaha, E Rencova, H Langrova, et al.
Atherosclerosis. Supplements|November 4, 2017
Plasma filtration for the controlled removal of liposomal therapeutics - From the apheretic site of viewM Blaha, J Martinkova, M Lanska, et al.
Atherosclerosis. Supplements|January 30, 2013
The decrease of mean platelet volume after extracorporeal LDL-cholesterol eliminationM Blaha, M Kostal, M Lanska, et al.
Atherosclerosis. Supplements|May 5, 2015
Changes of the complement system and rheological indicators after therapy with rheohemapheresisM Blaha, C Andrys, H Langrova, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 28, 2017
Apheresis data registration in WWA registry-10-year experience of our centerM Blaha, M Lanska, H Tomsova, et al.
Neurology|April 1, 2016
Author ResponseDouglas J Lanska, James M Lanska, Bernd F Remler
Neurology|June 3, 2015
Description and clinical application of the Pulfrich effectDouglas J Lanska, James M Lanska, Bernd F Remler
Atherosclerosis. Supplements|May 5, 2015
Pregnancy in homozygous familial hypercholesterolemia--Importance of LDL-apheresisM Blaha, M Lanska, V Blaha, et al.
Biomed Research International|October 3, 2014
Timing of peripheral blood stem cell yield: comparison of alternative methods with the classic method for CD34+ cell determinationI Fatorova, M Blaha, M Lanska, et al.
Journal of Biomedicine & Biotechnology|March 20, 2010
Extracorporeal immunoglobulin elimination for the treatment of severe myasthenia gravisM Blaha, J Pit'ha, V Blaha, et al.
Atherosclerosis. Supplements|January 30, 2013
Rheohaemapheresis in the treatment of nonvascular age-related macular degenerationM Blaha, E Rencova, H Langrova, et al.
Atherosclerosis. Supplements|November 4, 2017
Plasma filtration for the controlled removal of liposomal therapeutics - From the apheretic site of viewM Blaha, J Martinkova, M Lanska, et al.
Atherosclerosis. Supplements|January 30, 2013
The decrease of mean platelet volume after extracorporeal LDL-cholesterol eliminationM Blaha, M Kostal, M Lanska, et al.
Atherosclerosis. Supplements|May 5, 2015
Changes of the complement system and rheological indicators after therapy with rheohemapheresisM Blaha, C Andrys, H Langrova, et al.
Pageof 2